Washington-based Calmerry is a telepsychiatry platform that caters to a range of mental health conditions, including sleep disorders, post-traumatic stress disorder, obsessive-compulsive disorder, and depression. The company provides counselor-patient matching services and on-demand virtual consultations with licensed therapists via text and live video sessions. The subscription-based service begins at USD 42 per week, and the company claims to be relatively inexpensive compared to its competitors. The app-based platform also includes a mood tracker, guided journaling prompts, and worksheets for patients.
Founded in 2020, the company concluded a USD 5 million seed funding round in April 2021 to expedite membership growth, expand the product offerings available to both users and therapists, and recruit additional mental health professionals to the team.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.